Zielgruppe

TARGET GROUP
Scientists, technical experts, project and line managers from various areas of ocular drug product development involved into research and development of ophthalmic drug products for new drug candidates (small and large molecules).

Zielsetzung

Outline
There is an increasing interest in developing novel and improved medicines for the treatment of ocular diseases such as age related macular degeneration (AMD), diabetic retinopathies, glaucoma, dry eye.

World leading experts from Europe and America working in preclinical and clinical R&D areas in academia, industry and CROs will provide insights to formulation related development aspects and discuss adequate approaches such as: - Basic aspects of ocular diseases and treatment options by using modern drug delivery systems ranging from eye drops to controlled release systems- Drug transport and pharmacokinetics in the eye - Overview on available and novel formulations principles and drug delivery systems - Challenges and hurdles in the development of novel drug delivery concepts including packaging - Options for preclinical and clinical testing ocular delivery systems (CRO’s) - Case studies